Long COVID, characterized by persistent symptoms following a SARS-CoV-2 infection, affects approximately 10%-20% of individuals, presenting a significant challenge due to the lack of specific diagnostic and therapeutic tools. A recent study published in Science sheds light on the underlying mechanisms of long COVID, revealing dysregulation in the immune system’s
Beyond Dark Chocolate: Flavanol-Rich Foods May Reduce Risk for Essential Hypertension, Blood Clots • Flavanol-rich foods like dark chocolate could lower your risk of essential hypertension and blood clots. • A variety of flavanol-rich foods, including tea, berries, and grapes, offer antioxidant and anti-inflammatory cardiovascular benefits. • New research suggests
It is with a heavy heart that we announce the passing of Robert Jennejahn, a valued contributor to Vein Therapy News. His association with our book spanned several issues, during which he made significant contributions. On the 7th of October this year, Robert passed on at the age of 71.
We would like to hear from you! Please call Gary Pittman Jr at 512-637-0373 or email firstname.lastname@example.org.
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced observational data from 8 years of clinical practice showing that the company’s oral Factor Xa inhibitor Xarelto (rivaroxaban) is associated with comparable effectiveness and safety to the Factor Xa inhibitor apixaban for the treatment of cancer-associated thromboembolism (CAT) in a
Stryker announced FDA 510(k) clearance of the Target Tetra detachable coil, the latest addition to the company’s Target platform. The Target Tetra device, which is specifically designed to treat small aneurysms, combines a new tetrahedral shape and softness level. According to the company, the delicate nature of small aneurysms makes
Corindus, a Siemens Healthineers Company, announced it has been rebranded to Siemens Healthineers Endovascular Robotics, a dedicated business within the Advanced Therapies area of Siemens Healthineers. The aim of the Endovascular Robotics business is to advance interventions with robotics and change the way that care is delivered through innovations that
Cook Medical announced the appointment of John A. Kaufman, MD, MS, as Chief Medical Officer (CMO), effective July 2023. Currently, Dr. Kaufman is the inaugural Chair of the Dotter Department of Interventional Radiology, Director of the Dotter Interventional Institute, and Frederick S. Keller Professor of Interventional Radiology at the Oregon
Merit Medical Systems, Inc. announced the enrollment of the first patient in the company’s prospective, observational study of EmboCube embolization gelatin to control bleeding or hemorrhage. The EmboCube Embolization Gelatin study is designed to enroll 100 patients across multiple centers in Australia and France. The company advised that EmboCube is
Vesalio announced that data on the use of the company’s NeVa thrombectomy device were published by Arsida Bajrami, MD, et al in Interventional Neuroradiology. The company stated that the NeVa platform is designed to consistently achieve first-pass recanalization in stroke by effectively removing all types of neurovascular clots from a